U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07077291) titled 'MBCT and Escitalopram for Treatment-Resistant Depression in Older Adults' on July 11.
Brief Summary: This study is a randomized controlled trial designed to investigate the synergistic effects of combining mindfulness-based cognitive therapy (MBCT) with escitalopram hydrobromide versus escitalopram alone on cognitive function, depressive symptoms, and quality of life in older adults diagnosed with treatment-resistant depression (TRD) and cognitive impairment.
Study Start Date: Feb. 01, 2020
Study Type: INTERVENTIONAL
Condition:
Treatment-resistant Depression (TRD)
Intervention:
BEHAVIORAL: Mindfulness-Based Cognitive Therapy (...